A low dose of Vitamin D with non-steroidal anti- inflammatory drugs may prevent the growth of prostate cancer cells, says a study.
David Feldman and other researchers at Stanford University studied the effects of using calcitrol, a form of Vitamin D, combined with an over-the-counter anti-inflammatory drug on prostate cancer cultured cells, reports the online edition of Ivanhoe Broadcast News.
The researchers saw a 25 percent reduction in prostate cell growth using only calcitrol. They noticed approximately the same reduction using only ibuprofen or naproxen.
But the prostate cell growth came down by 70 percent when they combined calcitrol with ibuprofen or naproxen.
"Non-steroidal anti-inflammatory drugs (such as ibuprofen or naproxen) have their own risks," says Feldman.
"So, we have to be careful even with lower doses and we still need to watch them closely if we intend to keep them on these drugs for extended periods of time. But we are aiming to find doses that are less toxic and far more tolerable for the patient."
Source - IANS